2blc
From Proteopedia
Line 4: | Line 4: | ||
|PDB= 2blc |SIZE=350|CAPTION= <scene name='initialview01'>2blc</scene>, resolution 2.25Å | |PDB= 2blc |SIZE=350|CAPTION= <scene name='initialview01'>2blc</scene>, resolution 2.25Å | ||
|SITE= <scene name='pdbsite=AC1:Mes+Binding+Site+For+Chain+A'>AC1</scene> | |SITE= <scene name='pdbsite=AC1:Mes+Binding+Site+For+Chain+A'>AC1</scene> | ||
- | |LIGAND= | + | |LIGAND= <scene name='pdbligand=CP7:6-ETHYL-5-PHENYLPYRIMIDINE-2,4-DIAMINE'>CP7</scene>, <scene name='pdbligand=MES:2-(N-MORPHOLINO)-ETHANESULFONIC+ACID'>MES</scene>, <scene name='pdbligand=NDP:NADPH+DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE+PHOSPHATE'>NDP</scene> |
- | |ACTIVITY= [http://en.wikipedia.org/wiki/Dihydrofolate_reductase Dihydrofolate reductase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.5.1.3 1.5.1.3] | + | |ACTIVITY= <span class='plainlinks'>[http://en.wikipedia.org/wiki/Dihydrofolate_reductase Dihydrofolate reductase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.5.1.3 1.5.1.3] </span> |
|GENE= | |GENE= | ||
+ | |DOMAIN= | ||
+ | |RELATEDENTRY= | ||
+ | |RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2blc FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2blc OCA], [http://www.ebi.ac.uk/pdbsum/2blc PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=2blc RCSB]</span> | ||
}} | }} | ||
Line 30: | Line 33: | ||
[[Category: Walkinshaw, M D.]] | [[Category: Walkinshaw, M D.]] | ||
[[Category: Yuthavong, Y.]] | [[Category: Yuthavong, Y.]] | ||
- | [[Category: CP7]] | ||
- | [[Category: MES]] | ||
- | [[Category: NDP]] | ||
[[Category: dihydrofolate reductase]] | [[Category: dihydrofolate reductase]] | ||
[[Category: double mutant]] | [[Category: double mutant]] | ||
Line 42: | Line 42: | ||
[[Category: thymidylate synthase]] | [[Category: thymidylate synthase]] | ||
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Mar 31 02:08:06 2008'' |
Revision as of 23:08, 30 March 2008
| |||||||
, resolution 2.25Å | |||||||
---|---|---|---|---|---|---|---|
Sites: | |||||||
Ligands: | , , | ||||||
Activity: | Dihydrofolate reductase, with EC number 1.5.1.3 | ||||||
Resources: | FirstGlance, OCA, PDBsum, RCSB | ||||||
Coordinates: | save as pdb, mmCIF, xml |
SP21 DOUBLE MUTANT P. VIVAX DIHYDROFOLATE REDUCTASE IN COMPLEX WITH DES-CHLOROPYRIMETHAMINE
Overview
Pyrimethamine (Pyr) targets dihydrofolate reductase of Plasmodium vivax (PvDHFR) as well as other malarial parasites, but its use as antimalarial is hampered by the widespread high resistance. Comparison of the crystal structures of PvDHFR from wild-type and the Pyr-resistant (SP21, Ser-58 --> Arg + Ser-117 --> Asn) strain as complexes with NADPH and Pyr or its analog lacking p-Cl (Pyr20) clearly shows that the steric conflict arising from the side chain of Asn-117 in the mutant enzyme, accompanied by the loss of binding to Ser-120, is mainly responsible for the reduction in binding of Pyr. Pyr20 still effectively inhibits both the wild-type and SP21 proteins, and the x-ray structures of these complexes show how Pyr20 fits into both active sites without steric strain. These structural insights suggest a general approach for developing new generations of antimalarial DHFR inhibitors that, by only occupying substrate space of the active site, would retain binding affinity with the mutant enzymes.
About this Structure
2BLC is a Single protein structure of sequence from Plasmodium vivax. Full crystallographic information is available from OCA.
Reference
Crystal structure of dihydrofolate reductase from Plasmodium vivax: pyrimethamine displacement linked with mutation-induced resistance., Kongsaeree P, Khongsuk P, Leartsakulpanich U, Chitnumsub P, Tarnchompoo B, Walkinshaw MD, Yuthavong Y, Proc Natl Acad Sci U S A. 2005 Sep 13;102(37):13046-51. Epub 2005 Aug 31. PMID:16135570
Page seeded by OCA on Mon Mar 31 02:08:06 2008